| 936 |
Centers for Disease Control and Prevention |
Html |
en |
Histoplasmosis Associated with a Bamboo Bonfire - Arkansas,October 2011 |
Dirk T. Haselow, MD, PhD1, Haytham Safi, MD1, David Holcomb, MS1, Nathaniel Smith, MD1, Kendall D. Wagner, MD2, Branson B. |
| Histoplasma-related laboratory results | 0.625207 |
| Histoplasma capsulatum yeast | 0.690397 |
| primary care providers | 0.71569 |
| serum antigen results | 0.648883 |
| standard case definitions | 0.623255 |
| Arkansas primary care | 0.662067 |
| red-winged blackbird roost | 0.754672 |
| children | 0.636759 |
| ADH communicable disease | 0.613819 |
| infectious diseases specialist | 0.719963 |
| probable cases | 0.628207 |
| histoplasmosis | 0.976995 |
| antigen test results | 0.694859 |
| histoplasmosis cases | 0.734395 |
| attendees | 0.983607 |
| phoeniceus) roost. | 0.614765 |
| Younger attendees | 0.667709 |
| vague abdominal pain | 0.613986 |
| case definition | 0.651622 |
| primary care provider | 0.74757 |
| illness onset | 0.658887 |
| diffuse pulmonary histoplasmosis | 0.751033 |
| local primary care | 0.628303 |
| histoplasmosis contamination | 0.688599 |
|
| Repeat CXRs | 0.623976 |
| Histoplasma yeast | 0.736727 |
| Histoplasma yeast antibody | 0.669164 |
| abnormal CXR | 0.622935 |
| serum antigen test | 0.632692 |
| diffuse infiltrative disease | 0.61593 |
| appropriate medical care | 0.632946 |
| family gathering | 0.737778 |
| pediatric infectious diseases | 0.713837 |
| positive Histoplasma yeast | 0.691302 |
| small bamboo fort | 0.658835 |
| Histoplasma mycelial immunoglobulin | 0.69006 |
| bamboo grove understory | 0.663406 |
| local county health | 0.619075 |
| acute respiratory histoplasmosis | 0.742764 |
| histoplasmosis tests | 0.695547 |
| pulmonary histoplasmosis | 0.76875 |
| mycelial antibody | 0.632992 |
| bamboo grove | 0.68829 |
| chest pain | 0.641271 |
| Arkansas county health | 0.624657 |
| primary care | 0.762114 |
| urine antigen test | 0.624375 |
| ill attendees | 0.666752 |
|
CLICK HERE |
| 1158 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Coccidioides immitis Identified inSoil Outside of Its Known Range - Washington, 2013 |
Nicola Marsden-Haug, MPH1, Heather Hill2, Anastasia P. Litvintseva, PhD3, David M. Engelthaler, MS4, Elizabeth M. |
| South America | 0.718016 |
| new direct evidence | 0.78851 |
| Coccidioides infection | 0.786087 |
| specific therapy | 0.715004 |
| Residual pulmonary nodules | 0.814293 |
| environmental isolate genotypes | 0.811308 |
| Human Services | 0.778251 |
| endemic area | 0.724782 |
| Coccidioides DNA | 0.792707 |
| public health authorities | 0.796138 |
| MMWR HTML versions | 0.790525 |
| U.S. Department | 0.776503 |
| nearby rodent burrows | 0.797697 |
| all-terrain vehicle | 0.713889 |
| electronic PDF version | 0.790601 |
| Washington State Public | 0.830497 |
| chain reaction assay | 0.795319 |
| southwestern United States | 0.805331 |
| Contact GPO | 0.718261 |
| public lands | 0.710131 |
| soil samples | 0.963211 |
| yeast extract medium | 0.79199 |
| clinical manifestations | 0.724237 |
| original paper copy | 0.784317 |
|
| mild cases | 0.726714 |
| illness onset | 0.70995 |
| clinical isolate | 0.718523 |
| nationally notifiable disease | 0.793758 |
| C. immitis | 0.95473 |
| Benton County | 0.709609 |
| original MMWR paper | 0.798041 |
| U.S. Government Printing | 0.791175 |
| chronic lung disease | 0.810932 |
| south central Washington | 0.99589 |
| health-care providers | 0.795023 |
| residential complex | 0.710087 |
| novel real-time polymerase | 0.802109 |
| environmental testing methods | 0.806076 |
| clinically compatible illness | 0.792574 |
| Washington cases | 0.750584 |
| acute coccidioidomycosis cases | 0.913835 |
| public health | 0.803311 |
| Translational Genomics Research | 0.797069 |
| community-acquired pneumonia | 0.73481 |
| Health Laboratories | 0.71034 |
| Viable C. immitis | 0.885696 |
| valley fever | 0.719734 |
| soil-dwelling fungi Coccidioides | 0.936875 |
|
CLICK HERE |
| 5572 |
Centers for Disease Control and Prevention |
Html |
en |
Pyridine - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5975 |
Centers for Disease Control and Prevention |
Html |
en |
Thallium (soluble compounds, as Tl) - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6143 |
Centers for Disease Control and Prevention |
Html |
en |
Hospital Support for Breastfeeding - CDC Vital Signs |
CDC Vital Signs links science, policy, and communications with the intent of communicating a call-to-action for the public. CDC Vital Signs provides the most recent, comprehensive data on key indicators of important health topics. |
| hospitals | 0.530956 |
| American Academy | 0.434192 |
| Mortality Weekly Report | 0.413008 |
| breastfeeding rates | 0.666091 |
| maternity care policies | 0.435587 |
| Hospital Initiative | 0.43071 |
| federal hospitals | 0.408929 |
| Organization/UNICEF Baby-Friendly Hospital | 0.43432 |
| largest hospitals | 0.407908 |
| mothers | 0.699745 |
| Baby-Friendly hospitals | 0.41004 |
| Help mothers | 0.469602 |
| newborn infants | 0.371957 |
| hard time | 0.369521 |
| patient care teams | 0.418812 |
| Signs Issue details | 0.413675 |
| artificial nipples | 0.366017 |
| health care staff | 0.533013 |
| separate babies | 0.406643 |
| Low rates | 0.367726 |
| sure mothers | 0.475198 |
| lactation care | 0.376692 |
| Successful Breastfeeding | 0.916039 |
| support practices | 0.376484 |
|
| comienza al amamantar | 0.413132 |
| support breastfeeding | 0.624371 |
| Steps | 0.367454 |
| maternity care quality | 0.4342 |
| Help hospitals | 0.413841 |
| maternity care | 0.510166 |
| ovarian cancers | 0.366126 |
| babies | 0.460668 |
| hospital support | 0.391346 |
| mothers breastfeed | 0.549601 |
| Include lactation consultants | 0.418411 |
| clinic-based breastfeeding support | 0.679158 |
| infant death syndrome | 0.423635 |
| breastfeeding policy | 0.6414 |
| local hospitals | 0.407768 |
| counsel mothers | 0.448097 |
| breast milk | 0.496167 |
| Baby- Friendly Hospital | 0.439401 |
| support groups | 0.374557 |
| Track hospital policies | 0.424684 |
| Obesidad infantil | 0.365832 |
| overweight child | 0.385436 |
| childhood obesity | 0.436678 |
| maternity care practices | 0.434636 |
|
CLICK HERE |
| 6833 |
Centers for Disease Control and Prevention |
Html |
en |
Meningococcal - Signs and Symptoms |
meningococcal infection is characterized by a sudden onset of fever, headache, and stiff neck. It is often accompanied by other symptoms |
| fever | 0.244067 |
| bloodstream infection | 0.438892 |
| Page | 0.278331 |
| babies | 0.305492 |
| protective membranes | 0.427274 |
| matter | 0.245227 |
| additional symptoms | 0.412215 |
| common types | 0.405573 |
| meningococcal septicemia | 0.810244 |
| Newborns | 0.251438 |
| reflexes | 0.25622 |
| signs | 0.240152 |
| young children | 0.409537 |
| bacteria Neisseria | 0.493747 |
| spinal cord | 0.425093 |
|
| meningococcal infections | 0.656716 |
| Seek medical attention | 0.652661 |
| flu-like illness | 0.473168 |
| vomiting | 0.254309 |
| organs | 0.242503 |
| blood vessels | 0.396653 |
| brain | 0.242652 |
| meningococcal meningitis | 0.924856 |
| common symptoms | 0.401694 |
| symptoms | 0.633247 |
| classic symptoms | 0.398691 |
| doctor | 0.275828 |
| meningococcal disease | 0.898248 |
| doctors | 0.349132 |
| neck stiffness | 0.4303 |
|
CLICK HERE |
| 10489 |
Centers for Disease Control and Prevention |
Html |
en |
Email Updates: August 12, 2013'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| CDC | 0.969777 |
| Public Health Matters | 0.532799 |
| Emergency Preparedness | 0.495336 |
| Respiratory Syndrome Coronavirus | 0.762101 |
| FDA Safety Information | 0.484111 |
| – (CDC) | 0.630634 |
| new avian influenza | 0.488031 |
| CDC Science Clips | 0.733387 |
| Additional COCA Conference | 0.494579 |
| deadly diseases | 0.399726 |
| CDC Influenza Division | 0.700619 |
| new H7N9 virus | 0.479604 |
| important safety information | 0.468697 |
| novel coronavirus | 0.43388 |
| health care providers | 0.594752 |
| Weekly Flu View | 0.474222 |
| Free CE credit/contact | 0.470463 |
| human medical products | 0.457953 |
| World Health Organization | 0.508782 |
| Current Travel Warnings | 0.462403 |
| public health officials | 0.639047 |
| seasonal flu | 0.452049 |
| public health risks | 0.518397 |
| recent ACIP recommendations | 0.510738 |
|
| Event Reporting Program | 0.458708 |
| recent vaccine recommendations | 0.485611 |
| East Respiratory Syndrome | 0.827901 |
| Respiratory Illness Associated | 0.527093 |
| CDC Health Alert | 0.746839 |
| Health Professionals | 0.427117 |
| COCA Email Update | 0.528794 |
| public health community | 0.537596 |
| Immunization Practices | 0.406864 |
| Advisory Committee | 0.401722 |
| public health | 0.795142 |
| Specific Hazards preparedness | 0.489838 |
| Middle East Respiratory | 0.827968 |
| available immunization resources | 0.497259 |
| in-person training centers | 0.471267 |
| FoodSafety.gov Reports FDA | 0.47927 |
| severe respiratory illness | 0.657595 |
| weekly influenza surveillance | 0.469563 |
| carbon monoxide poisoning | 0.464146 |
| adult providers | 0.404246 |
| flu season | 0.40041 |
| USDA Food Recalls | 0.457235 |
| Response Training Resources | 0.484442 |
| CDC subject matter | 0.728394 |
|
CLICK HERE |
| 12176 |
Centers for Disease Control and Prevention |
Html |
en |
Estimated Influenza Illnesses and Hospitalizations Avertedby Vaccination - United States, 2013-14 Influenza Season |
Carrie Reed, DSc1, Inkyu Kevin Kim, PhD1, James A. Singleton, PhD2, Sandra S Chaves, MD1, Brendan Flannery, PhD1, Lyn Finelli, DrPh1, Alicia Fry, MD1, Erin Burns1, Paul Gargiullo, PhD1, Daniel Jernigan, MD1, Nancy Cox, PhD1, Joseph Bresee, MD1 (Author affiliations at end of text). |
| influenza | 0.990218 |
| influenza illnesses | 0.449957 |
| influenza vaccination recommendation | 0.470963 |
| United States | 0.47058 |
| influenza vaccination coverage | 0.734693 |
| age group | 0.431987 |
| adults | 0.313909 |
| averted hospitalizations | 0.331168 |
| Risk Factor Surveillance | 0.324233 |
| Influenza Vaccine Effectiveness | 0.446823 |
| lowest influenza vaccination | 0.538558 |
| estimated hospitalization rates | 0.317989 |
| influenza hospitalization rates | 0.44905 |
| influenza disease | 0.375489 |
| Factor Surveillance Survey | 0.324227 |
| current influenza vaccination | 0.469152 |
| influenza medical visits | 0.396093 |
| influenza vaccination levels | 0.526442 |
| vaccination status | 0.311089 |
| influenza illness | 0.38923 |
| Healthy People | 0.33277 |
| universal influenza vaccination | 0.475922 |
| National Center | 0.305592 |
| influenza season | 0.533703 |
|
| influenza activity | 0.419168 |
| influenza vaccines | 0.409176 |
| chain reaction–positive influenza | 0.423097 |
| influenza vaccination | 0.906088 |
| vaccine effectiveness | 0.605311 |
| influenza virus circulation | 0.44115 |
| influenza seasons | 0.416579 |
| persons | 0.43368 |
| influenza hospitalizations | 0.509246 |
| medically attended illnesses | 0.312213 |
| vaccine effectiveness data | 0.303437 |
| Influenza Division | 0.387587 |
| influenza testing | 0.442062 |
| annual influenza vaccination | 0.568167 |
| influenza viruses | 0.371064 |
| influenza deaths | 0.37379 |
| 2009 influenza pandemic | 0.432659 |
| influenza prevention | 0.375694 |
| Respiratory Diseases | 0.303914 |
| Vaccine effectiveness estimates | 0.36917 |
| fewer hospitalizations | 0.367362 |
| influenza-associated hospitalizations | 0.308555 |
| Behavioral Risk Factor | 0.327177 |
|
CLICK HERE |
| 12288 |
Centers for Disease Control and Prevention |
Html |
en |
Early Estimates of Seasonal Influenza Vaccine Effectiveness- United States, January 2015 |
Brendan Flannery, PhD1, Jessie Clippard, MPH1, Richard K. Zimmerman, MD2, Mary Patricia Nowalk, PhD2, Michael L. Jackson, PhD3, Lisa A. |
| season.†Influenza vaccination | 0.610187 |
| influenza A viruses | 0.623134 |
| Hemisphere influenza vaccine | 0.673356 |
| influenza antiviral medication | 0.621908 |
| current influenza season | 0.603245 |
| Health Research Institute | 0.475589 |
| confirmatory influenza laboratory | 0.605975 |
| self-rated health | 0.485541 |
| vaccination status | 0.517087 |
| vaccine virus component | 0.472098 |
| Influenza antiviral medications | 0.605736 |
| influenza illness | 0.572771 |
| health care providers | 0.48352 |
| influenza vaccine | 0.798068 |
| influenza activity | 0.688279 |
| antigenically drifted viruses | 0.528215 |
| Northern Hemisphere influenza | 0.594172 |
| uncomplicated influenza | 0.567085 |
| Hemisphere seasonal influenza | 0.620752 |
| influenza vaccine effectiveness | 0.724262 |
| Influenza Division | 0.563748 |
| high risk | 0.52815 |
| influenza prevention | 0.610105 |
| illness onset | 0.543412 |
|
| influenza | 0.952157 |
| U.S. Influenza Vaccine | 0.662109 |
| United States | 0.497604 |
| severe influenza season | 0.593762 |
| significant influenza activity | 0.591744 |
| vaccine viruses | 0.515238 |
| influenza B viruses | 0.635625 |
| seasonal influenza vaccine | 0.767952 |
| Southern Hemisphere influenza | 0.593168 |
| acute respiratory illness | 0.494709 |
| influenza season | 0.639173 |
| influenza vaccines | 0.635237 |
| patient vaccination status | 0.496917 |
| influenza vaccination | 0.633164 |
| influenza seasons | 0.569676 |
| laboratory-confirmed influenza virus | 0.624757 |
| influenza infections | 0.602193 |
| antiviral treatment | 0.51402 |
| ongoing influenza prevention | 0.608049 |
| influenza viruses | 0.696363 |
| study site | 0.481665 |
| additional influenza prevention | 0.589132 |
| overall vaccine effectiveness | 0.493258 |
| Northern Hemisphere vaccine | 0.4716 |
|
CLICK HERE |
| 12403 |
Centers for Disease Control and Prevention |
Image |
null |
Timeline for Anthrax Laboratory Incident (1185W x 916H) |
null |
|
|
CLICK HERE |